Buscar resultados de ensayos clínicos
Hemoglobinuria - 76 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Proof of Concept Study to Assess the Efficacy, Safety and Pharmacokinetics of LFG316 in Patients With Paroxysmal Nocturnal Hemoglobinuria Condición: Paroxysmal Nocturnal Hemoglobinuria PNH Fecha: 2015-08-07 Intervenciones: Biological: LFG316 LFG316 will be administered to all patients enrolled in the study |
Terminated |
Nombre del estudio: Safety and Pharmacokinetics of TT30 in Subjects With Paroxysmal Nocturnal Hemoglobinuria (PNH) Condición: Paroxysmal Nocturnal Hemoglobinuria (PNH) Fecha: 2011-04-12 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: ALXN1210 Versus Eculizumab in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab Condición: Paroxysmal Nocturnal Hemoglobinuria (PNH) Fecha: 2017-02-14 Intervenciones:
|
Recruiting |
Nombre del estudio: ALXN1210 Versus Eculizumab in Complement Inhibitor Treatment-Naïve Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Condición: Paroxysmal Nocturnal Hemoglobinuria (PNH) Fecha: 2016-10-25 Intervenciones:
|
Completed |
Nombre del estudio: Eculizumab Pharmacokinetics/Pharmacodynamics Study in Pediatric/Adolescent PNH Subjects Condición: Hemoglobinuria, Paroxysmal Fecha: 2009-03-23 Intervenciones: Drug: Eculizumab Other Name: Soliris |
Completed |
Nombre del estudio: Paroxysmal Nocturnal Hemoglobinuria Human Anti-Human Antibodies Study Condición:
Fecha: 2011-08-05 |
Completed |
Nombre del estudio: Extension Study of Eculizumab in Patients With Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) Condición: Paroxysmal Hemoglobinuria, Nocturnal Fecha: 2005-07-20 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: A Open-label, Multiple Ascending Dose Study to Evaluate the Efficacy, Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of ALXN1210 Administered Intravenously to Patients With Paroxysmal Nocturnal Hemoglobinuria Condición:
Fecha: 2015-11-11 Intervenciones:
|
Approved for marketing |
Nombre del estudio: The Paroxysmal Nocturnal Hemoglobinuria Early Access Treatment Protocol Condición: Hemoglobinuria, Paroxysmal Fecha: 2007-02-20 Intervenciones: Drug: eculizumab 600mg IV every week and 900mg IV every 2 weeks |
Completed |
Nombre del estudio: Study Using Eculizumab in Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Condición: Hemoglobinuria, Paroxysmal Fecha: 2005-07-18 Intervenciones: Drug: eculizumab |